ATE207545T1 - Indikator - zelllinie und eine methode für rns- virusnachweis - Google Patents
Indikator - zelllinie und eine methode für rns- virusnachweisInfo
- Publication number
- ATE207545T1 ATE207545T1 AT95905369T AT95905369T ATE207545T1 AT E207545 T1 ATE207545 T1 AT E207545T1 AT 95905369 T AT95905369 T AT 95905369T AT 95905369 T AT95905369 T AT 95905369T AT E207545 T1 ATE207545 T1 AT E207545T1
- Authority
- AT
- Austria
- Prior art keywords
- reporter gene
- rna
- cell
- specimen
- cell lines
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title abstract 2
- 108700008625 Reporter Genes Proteins 0.000 abstract 6
- 108020004414 DNA Proteins 0.000 abstract 3
- 241001493065 dsRNA viruses Species 0.000 abstract 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/171,214 US5591579A (en) | 1993-12-21 | 1993-12-21 | Indicator cell line for detecting RNA viruses and method therefor |
| PCT/US1994/014332 WO1995017525A1 (en) | 1993-12-21 | 1994-12-20 | Indicator cell line for detecting rna viruses and method therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE207545T1 true ATE207545T1 (de) | 2001-11-15 |
Family
ID=22622949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95905369T ATE207545T1 (de) | 1993-12-21 | 1994-12-20 | Indikator - zelllinie und eine methode für rns- virusnachweis |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5591579A (de) |
| EP (1) | EP0738332B1 (de) |
| JP (1) | JPH09506776A (de) |
| AT (1) | ATE207545T1 (de) |
| AU (1) | AU691551B2 (de) |
| CA (1) | CA2178004C (de) |
| DE (1) | DE69428806T2 (de) |
| ES (1) | ES2166394T3 (de) |
| WO (1) | WO1995017525A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US5952172A (en) | 1993-12-10 | 1999-09-14 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US5824473A (en) | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| KR100495690B1 (ko) | 1996-01-26 | 2005-11-08 | 비르코 비브이비에이 | 인체 hiv 계통의 표현형적 약제 감수성에 기초한 하나 이상의 최적한 hiv 저해제를 선발하는 방법 |
| US6458560B1 (en) | 1996-04-05 | 2002-10-01 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| US6451592B1 (en) | 1996-04-05 | 2002-09-17 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| US5945276A (en) * | 1996-04-10 | 1999-08-31 | Signal Pharmaceuticals, Inc. | Reporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expression |
| US5910411A (en) * | 1996-09-30 | 1999-06-08 | Signal Pharmaceuticals, Inc. | Method for identifying agents that modulate transcription of human cytomegalovirus polymerase |
| US5994136A (en) * | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| US20030074677A1 (en) * | 1998-05-22 | 2003-04-17 | Lada Rasochova | Improved materials and methods for transformation |
| US6270958B1 (en) * | 1998-10-29 | 2001-08-07 | Washington University | Detection of negative-strand RNA viruses |
| EP1129178A4 (de) * | 1998-11-13 | 2002-08-21 | Cell Genesys Inc | Empfindliches 'screening'-system für rekombinante viren mit defekter hülle. |
| US6136538A (en) * | 1999-01-08 | 2000-10-24 | Washington University | Silent inducible virus replicons and uses thereof |
| US6326480B1 (en) | 1999-01-19 | 2001-12-04 | Signal Pharmaceuticals, Inc. | Antisense reporter system for assaying RNA virus replication |
| DE60044125D1 (de) * | 1999-04-14 | 2010-05-20 | Novartis Vaccines & Diagnostic | Zusammensetzungen und verfahren zur auslösung einer immunantwort auf basis alphavirus-vektoren-systeme |
| US8647864B2 (en) * | 1999-04-14 | 2014-02-11 | Novartis Ag | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| ATE528406T1 (de) | 1999-04-29 | 2011-10-15 | Gbp Ip Llc | Verfahren und mittel zur herstellung von sicheren,rekombinanten lentivirusvektoren mit hohem titer |
| JP2003501073A (ja) * | 1999-06-03 | 2003-01-14 | トーマス・ジェファーソン・ユニバーシティ | 安定的にhcvを形質移入したhepg2細胞 |
| US6767699B2 (en) | 2000-05-31 | 2004-07-27 | Chiron Corporation | Method for the quantitation of alphavirus replicon particles |
| US7279275B2 (en) | 2003-11-03 | 2007-10-09 | Washington University | Methods and compositions for detection of segmented negative strand RNA viruses |
| EP1737987B1 (de) * | 2003-12-08 | 2010-11-03 | Loma Linda University | Verfahren zum Nachweis von Pockenviren |
| WO2017205668A1 (en) * | 2016-05-25 | 2017-11-30 | Arizona Board Of Regents On Behalf Of Arizona State University | Portable, low-cost pathogen detection and strain identification platform |
| GB2589171A (en) * | 2020-07-22 | 2021-05-26 | Secr Defence | RNA Virus detection method |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4719177A (en) * | 1981-04-20 | 1988-01-12 | Massachusetts Institute Of Technology | Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor |
| GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
| AU638411B2 (en) * | 1988-02-26 | 1993-07-01 | Large Scale Biology Corporation | Non-nuclear chromosomal transformation |
| US5070012A (en) * | 1988-03-30 | 1991-12-03 | The Board Of Trustees Of The Leland Stanford Junior University | Monitoring of cells and trans-activating transcription elements |
| US5217879A (en) * | 1989-01-12 | 1993-06-08 | Washington University | Infectious Sindbis virus vectors |
| WO1991000047A1 (en) * | 1989-06-30 | 1991-01-10 | The Regents Of The University Of California | Retrovirus detection |
| FR2651005B1 (fr) * | 1989-08-17 | 1992-01-03 | Pasteur Institut | Lignees de cellules infectables par un retrovirus et contenant un marqueur activable a l'occasion de l'infection |
| EP0497894A4 (en) * | 1989-10-25 | 1993-03-31 | The Salk Institute For Biological Studies | Receptor infection assay |
| CA2044679A1 (en) * | 1990-06-22 | 1991-12-23 | Alexander Honigman | Detection of hiv infection by bioluminescence |
-
1993
- 1993-12-21 US US08/171,214 patent/US5591579A/en not_active Expired - Lifetime
-
1994
- 1994-12-20 JP JP7517488A patent/JPH09506776A/ja active Pending
- 1994-12-20 DE DE69428806T patent/DE69428806T2/de not_active Expired - Lifetime
- 1994-12-20 ES ES95905369T patent/ES2166394T3/es not_active Expired - Lifetime
- 1994-12-20 WO PCT/US1994/014332 patent/WO1995017525A1/en not_active Ceased
- 1994-12-20 CA CA002178004A patent/CA2178004C/en not_active Expired - Lifetime
- 1994-12-20 AT AT95905369T patent/ATE207545T1/de not_active IP Right Cessation
- 1994-12-20 EP EP95905369A patent/EP0738332B1/de not_active Expired - Lifetime
- 1994-12-20 AU AU14010/95A patent/AU691551B2/en not_active Expired
-
1996
- 1996-12-31 US US08/774,406 patent/US5851757A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2166394T3 (es) | 2002-04-16 |
| CA2178004A1 (en) | 1995-06-29 |
| DE69428806D1 (de) | 2001-11-29 |
| DE69428806T2 (de) | 2002-09-12 |
| AU1401095A (en) | 1995-07-10 |
| CA2178004C (en) | 2001-11-27 |
| AU691551B2 (en) | 1998-05-21 |
| EP0738332A1 (de) | 1996-10-23 |
| US5851757A (en) | 1998-12-22 |
| WO1995017525A1 (en) | 1995-06-29 |
| JPH09506776A (ja) | 1997-07-08 |
| EP0738332B1 (de) | 2001-10-24 |
| US5591579A (en) | 1997-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE207545T1 (de) | Indikator - zelllinie und eine methode für rns- virusnachweis | |
| Chang et al. | Studies of mouse mitochondrial DNA in Escherichia coli: structure and function of the eucaryotic-procaryotic chimeric plasmids | |
| Weigel et al. | Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma | |
| Clewley et al. | Purification and polypeptide composition of Semliki Forest virus RNA polymerase | |
| Zipser et al. | Mapping functional domains in the promoter region of the herpes thymidine kinase gene. | |
| Kelley et al. | Functional defects of pathogenic human mitochondrial tRNAs related to structural fragility | |
| Hestekin et al. | The potential of electrophoretic mobility shift assays for clinical mutation detection | |
| Neidhardt et al. | Selective synthesis of plasmid-coded proteins by Escherichia coli during recovery from chloramphenicol treatment | |
| Jagodnik et al. | Mechanistic study of base-pairing small regulatory RNAs in bacteria | |
| Fischer et al. | Bacteriophage T7 DNA replication in vitro. Stimulation of DNA synthesis by T7 RNA polymerase. | |
| Schmeer et al. | Pharmaceutical grade large-scale plasmid DNA manufacturing process | |
| Arsène et al. | Role of region C in regulation of the heat shock gene-specific sigma factor of Escherichia coli, ς32 | |
| Guille et al. | Methods for the analysis of DNA-protein interactions | |
| Simon et al. | Applications of chimeric genes and hybrid proteins, Part A: Gene expression and protein purification | |
| Hong et al. | Analyzing viral epitranscriptomes using nanopore direct RNA sequencing | |
| Hagen et al. | The role of template-primer interactions in cleavage and initiation by the influenza virus polymerase | |
| CN109486903A (zh) | 一种用于将拭子上的细胞洗脱、裂解释放核酸的洗脱裂解液、试剂盒和方法 | |
| Light et al. | Expression of a copy number control gene (copB) of plasmid R1 is constitutive and growth rate dependent | |
| CN112553378B (zh) | 检测2019-nCoV的试剂、试剂盒及应用 | |
| Berkner et al. | Characterization of the transcriptional activity of the cryptic plasmid pRN1 from Sulfolobus islandicus REN1H1 and regulation of its replication operon | |
| Xu et al. | Advances in methods and software for RNA cytosine methylation analysis | |
| CN113913406B (zh) | 一种用于检测SARS-CoV-2 69:70del位点的方法 | |
| CN116804216A (zh) | 一种含5hmC单细胞的检测方法 | |
| Olivo et al. | Indicator cell line for detecting RNA viruses and method therefor | |
| Shen et al. | Functional inactivation of lac alpha-peptide mRNA by a factor that purifies that Escherichia coli RNase III. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |